Search
for
Sort by
Research 571–600 of 1000+
- Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study
- Prognostic factors that affect the response to topical treatment in patchy alopecia areata
- Congenital triangular alopecia: A close mimicker of alopecia areata
- Audiological abnormalities in patients with alopecia areata
- Update on the Treatment of Alopecia Areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Association of vitamin D level with alopecia areata
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Oxidative stress and alopecia areata
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- Alopecia areata
- Congenital Combined Melanocytic Nevus of the Scalp With Associated Alopecia Areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Design and development of Epigallocatechin gallate and Fenugreek seed extract loaded Nanosponge based Aloevera gel for treating Alopecia Areata
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- A comparative study on therapeutic efficacy between topical dinitrochlorobenzene and topical betamethasone in alopecia areata
- Association between air quality index and risk of alopecia areata: A nationwide population-based cohort study
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Body circumference dimensions in Ukrainian men with alopecia areata
- Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata
- Evidence-Based Homeopathy: A case study on alopecia areata in a 6-year-old child
- Evaluation of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, CRP and ESR with disease severity in patients with alopecia areata
- Ritlecitinib in severe alopecia areata: a profile of its use
- Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
- A case of alopecia areata after rabies vaccination: unreported adverse effect?